Q32 Bio (QTTB) Debt Ratio (2023 - 2026)
Q32 Bio's (QTTB) quarterly Debt Ratio came in at 0.13 in Q1 2026, down 20.04% year-on-year from 0.16 in Q1 2025, and down 18.27% quarter-over-quarter from 0.16 in Q4 2025.
Q32 Bio (QTTB) Debt Ratio (2023 - 2026) Analysis & Trends
Q32 Bio's Debt Ratio history runs 4 years deep, the most recent figure standing at 0.13 for Q1 2026.
- On a quarterly basis, Debt Ratio fell 20.04% year-over-year to 0.13 in Q1 2026; TTM through Mar 2026 was 0.13, a 20.04% decrease from a year earlier, with the FY2025 full-year figure at 0.16, up 14.67% from the prior year.
- Debt Ratio slipped to 0.13 in Q1 2026 per QTTB's latest filing, from 0.16 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.19 in Q3 2025 and bottomed at 0.08 in Q1 2024.
- The 4-year median for Debt Ratio is 0.13 (2024), against an average of 0.14.
- Across the five-year window, Debt Ratio jumped 95.94% in 2025 and slipped 20.04% in 2026, its largest moves.
- Year by year, Debt Ratio stood at 0.12 in 2023, then grew by 18.13% to 0.14 in 2024, then advanced by 14.67% to 0.16 in 2025, then retreated by 18.27% to 0.13 in 2026.
- Per Business Quant, the three latest QTTB Debt Ratio figures stand at 0.13 (Q1 2026), 0.16 (Q4 2025), and 0.19 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Q32 Bio | 225.00 Mn | 174.25 Mn | - | 0.13 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.13 |
| Dec 31, 2025 | 0.16 |
| Sep 30, 2025 | 0.19 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | 0.16 |
| Dec 31, 2024 | 0.14 |
| Sep 30, 2024 | 0.12 |
| Jun 30, 2024 | 0.10 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 0.12 |